Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 78,596 | 72,060 | 6,034 | 26,735 | 59,998 |
| Depreciation Amortization | 110,818 | 104,660 | 109,654 | 117,178 | 82,386 |
| Income taxes - deferred | 4,499 | -6,749 | 1,138 | 4,967 | 2,170 |
| Accounts receivable | -11,708 | -4,248 | -1,175 | 4,733 | -6,397 |
| Other Working Capital | -14,915 | -13,681 | -1,757 | -4,779 | -559 |
| Other Operating Activity | 12,480 | 3,150 | 15,362 | -1,465 | 2,089 |
| Operating Cash Flow | $179,770 | $155,192 | $129,256 | $147,369 | $139,687 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -674,402 | -366,662 | -185,174 | -323,264 | -241,674 |
| Net Acquisitions | N/A | N/A | -16,059 | -4,100 | N/A |
| Other Investing Activity | 11,059 | -45,089 | 19,633 | 22,116 | 16,319 |
| Investing Cash Flow | $-663,343 | $-411,751 | $-181,600 | $-305,248 | $-225,355 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,605,564 | 704,340 | 552,540 | 748,731 | 372,510 |
| Debt Repayment | -1,143,908 | -522,486 | -496,270 | -581,739 | -245,136 |
| Common Stock Issued | 103,457 | 28,173 | 0 | 4,747 | 141 |
| Common Stock Repurchased | -40,869 | N/A | -9,176 | -12,997 | -31,395 |
| Dividend Paid | -3,260 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -8,634 | 41,195 | -1,515 | -2,206 | -978 |
| Financing Cash Flow | $512,350 | $251,222 | $45,579 | $156,536 | $95,142 |
| Exchange Rate Effect | -3 | 220 | -674 | 75 | -1,394 |
| Beginning Cash Position | 47,209 | 52,326 | 59,765 | 53,821 | 45,741 |
| End Cash Position | 75,983 | 47,209 | 52,326 | 52,553 | 53,821 |
| Net Cash Flow | $28,774 | $-5,117 | $-7,439 | $-1,268 | $8,080 |
| Free Cash Flow | |||||
| Operating Cash Flow | 179,770 | 155,192 | 129,256 | 147,369 | 139,687 |
| Capital Expenditure | -740,004 | -432,336 | -251,247 | -389,414 | -307,311 |
| Free Cash Flow | -560,234 | -277,144 | -121,991 | -242,045 | -167,624 |